STOCK TITAN

Mineralys Therapeutics (NASDAQ: MLYS) files Form 144 to sell 4,584 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Mineralys Therapeutics (MLYS) filed a Form 144 stating an intended sale of 4,584 shares of common stock in a broker assisted cashless exercise related to an exercise of employee stock options on 06/17/2026. The filing lists prior open-market sales by David Rodman from 03/12/2026 through 06/15/2026 with multiple share quantities and dollar amounts.

Positive

  • None.

Negative

  • None.

Insights

Notice of intended affiliate sale via Form 144; routine compliance filing.

The filing documents an intended sale of 4,584 shares via a broker assisted cashless exercise on 06/17/2026. Form 144 is a statutory notice required for certain affiliate dispositions; it does not by itself confirm execution.

Prior sales by David Rodman are listed with dates and proceeds through 06/15/2026. Cash‑flow treatment and whether the listed sale executed are not stated in the excerpt; subsequent filings or trade reports would show execution details.

Intended shares to be sold 4,584 shares exercise of employee stock options on 06/17/2026
Aggregate amount shown (line item) 114600.00 line entry associated with the 4,584 shares (exact label in excerpt)
Shares outstanding line (excerpt) 82,498,101 appears in same line as securities info with date 06/17/2026
Representative prior sale 6,348 shares sale by David Rodman on 03/12/2026 with proceeds 173,748.15
Most recent prior sale (excerpt) 9,890 shares sale by David Rodman on 06/15/2026 with proceeds 235,487.24
Form 144 regulatory
"filed a Form 144 stating an intended sale of 4,584 shares"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
broker assisted cashless exercise financial
"Broker assisted cashless exercise"
exercise of employee stock options financial
"Exercise of employee stock options"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Mineralys Therapeutics' Form 144 for MLYS report?

The Form 144 reports an intended sale of 4,584 shares via a broker assisted cashless exercise tied to an exercise of employee stock options scheduled on 06/17/2026. It also lists prior sales by David Rodman between March and June 2026.

Who is the selling party listed in the filing for MLYS?

The filing references sales by David Rodman, listing multiple open‑market transactions from 03/12/2026 through 06/15/2026 with specific share counts and dollar amounts shown for each trade.

Does the Form 144 confirm the shares were sold for MLYS?

No. The Form 144 is a notice of an intended affiliate disposition; it indicates the proposed method (broker assisted cashless exercise) and date 06/17/2026 but does not by itself confirm execution or final proceeds.

What prior transactions are listed in the MLYS excerpt?

The excerpt lists multiple prior Common Stock sales by David Rodman, including trades on 03/12/2026, 03/13/2026, and continuing through 06/15/2026, with individual share counts and dollar proceeds shown for each entry.

What method is described for the 06/17/2026 MLYS transaction?

The filing specifies the method as a broker assisted cashless exercise arising from an exercise of employee stock options and lists the security as Common stock with the action dated 06/17/2026.